| Date Filed | Type | Description |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/10/2022 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 26,800 options
@ $2.5, valued at
$67k
|
|
| 12/03/2021 |
3
| BRANCACCIO JOHN P (Director) has filed a Form 3 on Accustem Sciences Inc. |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Bought 7,000 shares
@ $1.53, valued at
$10.7k
|
|
| 08/21/2020 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options
@ $3.72, valued at
$111.6k
|
|
| 06/19/2020 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 28,858 options
@ $2.6, valued at
$75k
|
|
| 05/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2020 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options
@ $1.63, valued at
$97.8k
|
|
| 07/25/2019 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Hepion Pharmaceuticals, Inc.|
Txns:
| Granted 970 options
@ $3.24, valued at
$3.1k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2018 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 13,896 shares
@ $0
Exercised 50,023 options
@ $0.5, valued at
$25k
|
|
| 07/03/2018 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc.|
Txns:
| Bought 3 convertible preferred
@ $1000, valued at
$3k
Bought 1,725 warrants
@ $1.55, valued at
$2.7k
|
|
| 06/19/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2018 |
4/A
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Bought 10,000 shares
@ $0.8, valued at
$8k
|
|
| 06/11/2018 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Bought 10,000 shares
@ $0.8, valued at
$8k
|
|
| 04/02/2018 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Exercised 50,000 options
@ $0.5, valued at
$25k
|
|
| 01/25/2018 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 54,322 options
@ $0.3, valued at
$16.3k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/20/2016 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on ContraVir Pharmaceuticals, Inc. |
| 06/29/2016 |
4/A
| BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 62,500 options
@ $3.67, valued at
$229.4k
|
|
| 06/27/2016 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 62,500 options
@ $3.67, valued at
$229.4k
|
|
| 01/06/2016 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on Trovagene, Inc.|
Txns:
| Granted 16,000 options
@ $5.18, valued at
$82.9k
|
|
| 07/28/2015 |
4
| BRANCACCIO JOHN P (Director) has filed a Form 4 on SYNERGY PHARMACEUTICALS, INC.|
Txns:
| Granted 37,000 options
@ $7.91, valued at
$292.7k
|
|
|